Serum stimulates the production of prostaglandins by transformed mouse fibroblasts. Hydrocortisone (cortisol) inhibits this stimulation. The half-maximal inhibition occurs at 6 X 10-9 M. Studies with cells labeled with [3Hlara-chidonic acid in their lipids show that the stimulation by serum results in the release of arachidonic acid from the cellular lipids, mostly phospholipids. Hydrocortisone inhibits this release but does not inhibit the production of prostaglandins from exogenously supplied arachidonic acid. This inhibition of arachidonic acid release from phospholipids may be the mechanism for the anti-inflammatory action of corticosteroids. Prostaglandins E2 and F2a (PGE2 and PGF2a) are present in the culture medium of a methylcholanthrene-transformed mouse fibroblast, MC5-5 (1, 2). This cell line proves to be a useful model for the study of the effect of vasoactive substances on the production of prostaglandins. We have shown that mechanical manipulation and vasoactive substances such as bradykinin, arachidonic acid, serum, and thrombin stimulate the production of prostaglandins. Cofactors for in vitro microsomal prostaglandin synthetase systems, such as hydroquinone and glutathione, also stimulate prostaglandin synthesis by the cells. Indomethacin, a nonsteroid anti-inflammatory drug, inhibited all of the above-mentioned stimulations of prostaglandin formation.
Prostaglandins have been implicated in inflammation (3) . Nonsteroid, aspirin-like anti-inflammatory drugs such as aspirin and indomethacin inhibit in vitro microsomal prostaglandin biosynthesis, and this inhibition has been postulated to be the basis of their therapeutic effects (4) . On the other hand, hydrocortisone (cortisol), an anti-inflammatory steroid, did not inhibit in vitro prostaglandin synthetase systems in some studies (4, 5) ; but in another study fluocinolone, at high concentrations, did inhibit (6) . Corticosteroids do inhibit prostaglandin formation by mouse fibrosarcoma cells (7) and by rheumatoid synovia (8) . Lewis and Piper, based on their study on the infusion of adrenocorticotropic hormone into rabbit adipose depots, concluded that inhibition of release of prostaglandins from the tissue was the mechanism of some actions of corticosteroids in inflammation, in gastric mucosa, and in the central nervous system (9) . Gryglewski et al. (10) , working with perfused guinea pig lungs, suggested that corticosteroids act by reducing the availability of the substrate for the prostaglandin synthetase.
The mechanism involving inhibition of release would be less likely if tissue storage of prostaglandins were low, as has been suggested by Ramwell and Shaw (11) . In this paper, we report studies on the effect of hydrocortisone on prostaglandin synthesis in MC5-5 cells and provide evidence for the mechanism of the action of corticosteroids in inhibiting prostaglandin synthesis.
Abbreviations: PGE2, prostaglandin E2; PGF2a, prostaglandin F2a.
MATERIALS AND METHODS
Cell and Cell Culture. MC5-5, a methylcholanthrenetransformed mouse BALB/3T3 cell line (12) was generously provided to us by Dr. G. J. Todaro. Cells were grown in Eagle's minimal essential medium supplemented with 10% (vol/vol) fetal bovine serum as previously described (1, 2) .
Exponentially growing MC5-5 cells were used for all experiments. Cells treated with trypsin were seeded at 2 to 5 X 105 cells per 60 mm Falcon tissue culture dish in 4 ml of the serum-supplemented medium and grown for 1 day. For experiments that~require changes to fresh medium for incubation, the dishes were washed two times with 2 ml of serum-free medium and 2 ml of the experimental medium was then added and the plates were incubated in a humidified incubator at 370 in an atmosphere of 95% air and 5% CO. After a desired time interval, medium was withdrawn, chilled, and stored at -20°.
When preincubatio'n with the drugs was required, the drugs were added to the culture for the desired length of time. The densities of the cells were not the same from experiment to experiment, but within each series of experiments, identically prepared cell dishes were used. Duplicate plates were used for all experiments. The analyses of the prostaglandin levels and radioactivity from duplicate dishes agreed within 5% of the mean value. PGE2 and PGF2a were measured serologically with either anti-PGE2 or anti-PGF2a as previously described (1, 2 [5,6,8,9,11,12,14,15- For thin-layer chromatography, Eastman Kodak chromatogram sheets with silica gel adsorbent and fluorescent indicator were used. For the analysis of radioactive material released from the cells, aliquots of the medium were directly applied to the sheets and developed with a solvent system described by Lands and Samuelsson (13) . For analysis of the composition of cell lipids containing [3H]arachidonic acid, the lipids were extracted with chloroform/methanol (2:1 vol/vol), and aliquots of the extract were applied to the sheets and developed by two-dimensional chromatography with the solvent systems described by Ames (14) . For (1, 2) . When the dishes containing growing cells were rinsed and incubated with medium containing serum, the prostaglandin levels in the medium increased with time for several hours before reaching a constant value. These maximum levels were proportional to the cell number in the dishes up to 2 X 106 cells per dish.
As shown in Fig. 1A , hydrocortisone inhibits the production of prostaglandins by MC5-5 cells. In this experiment, cells were incubated for 3 hr with fresh serum-supplemented medium containing various concentrations of hydrocortisone. The inhibition of PGE2 and PGF2a production was found to be dependent on hydrocortisone concentration and reached a maximum of 50% at 10-7 M. The half-maximal inhibition occurred at 6 X 10-9 M. In a similar study, indomethacin, a known inhibitor of prostaglandin synthetase, inhibited 50% at 10-7 M (Fig. 1B) . At MC5-5 cells at 1.3 X 106 per dish were preincubated for 2 hr with the indicated steroids at 5 x 10-6 M. The dishes were then rinsed and incubated with serum-supplemented medium containing the steroids for l hr, and the prostaglandins produced were assayed as described in Materials and Methods. The levels of prostaglandin are expressed as percent of control (PGE2, 13 ng/ml; PGF2a, 1.0 ng/ml) and the average values from duplicate dishes are shown.
preincubation was necessary to reach the 60% level of inhibition. However, if the cells were pretreated with hydrocortisone for 1 or 2 days, the inhibition was almost complete. The continuous presence of hydrocortisone in the medium after pretreatment was required, since the extent of inhibition was reduced if hydrocortisone was not present. Similar studies with indomethacin indicated that even a 10 min preincubation was sufficient to cause complete inhibition of prostaglandin production.
Not all of the steroids tested inhibited prostaglandin production; only steroids with anti-inflammatory activity did (Table 1) . In these experiments, cells were pretreated for 2 hr with the steroids at 5 X 10-6 M and then incubated for 1 hr with fresh serum-supplemented medium containing the steroids. Dexamethasone is the most potent, with 71% inhibition of PGE2 production, followed by hydrocortisone (59%) and corticosterone (39%). Deoxycorticosterone, estradiol-17,B, and estrone are only slightly inhibitory (10-20%), while cholesterol, epitestosterone, and dehydroisoandrosterone did not show significant effects. The order of the extent of inhibition by corticosteroids follows that of their relative anti-inflammatory potency. Similar results were also observed when PGF2 levels were determined, with the exception of deoxycorticosterone, which showed activity between that of hydrocortisone and corticosterone.
We had previously shown that serum stimulates the production of prostaglandins (1, 2) . With the use of cells labeled in phospholipids with [3H]arachidonic acid, we found that the presence of serum also stimulated the release of the prostaglandin precursor, arachidonic acid, from the cells. The data in Fig. 2 show that a significant amount of radioactivity was released into the medium, which after 3 hr amounted to about 20% of the total radioactivity incorporated into the cells. Analysis of the radioactive material by thin-layer chromatography indicated that arachidonic acid was the major component and accounted for 92% of the radioactivity, while the radioactivity with an RF value corresponding to PGE2 was about 4% of the total radioactivity released. The PGF2a and the phospholipid spots contained minor amounts of radioactivity (0.6% and 1%, respectively). Minor amounts of radioactivity, 1% and 1.5%, were associated with two unidentified spots; one running with the solvent front, and the other immediately behind arachidonic acid. The radioactivity associated with arachidonic acid were rinsed and incubated with 2 ml of the desired medium for 2 hr. In the presence of hydrocortisone or indomethacin the dishes were preincubated with the drugs at 5 x 10-6 M for 2 hr. The media were withdrawn and counted for radioactivity. The radioactivity remaining in the cells after the incubation was obtained by counting the trypsinized cell suspension. The initial radioactivity in the cells was obtained by subtracting the total radioactivity used for labeling from that remaining in the medium after 1 day of incorporation. Average values from duplicate dishes are shown. * Expressed as percent of the initial radioactivity in the cells.
of the total incorporated radioactivity was released. When the cells were treated with indomethacin, the released radioactivity was only slightly reduced (to 16%). However, when the cells were treated with hydrocortisone, the released radioactivity was markedly reduced (to 9.7%).
The radioactive materials released under the above conditions were analyzed by thin-layer chromatography. As shown in Fig. 3 as PGF2a, and 1% remained at the origin. Incubation of the cells with serum-supplemented medium containing hydrocortisone resulted in a 50% reduction of the released radioactive arachidonic acid. A simultaneous reduction of radioactive PGE2 and PGF2. was also observed. Although indomethacin did not cause any significant change in radioactive arachidonic acid, it completely inhibited the appearance of radioactive PGE2 and PGF2a. Indomethacin inhibited the conversion of arachidonic acid to PGE2 and PGF2a, whereas hydrocortisone exerted its effect by inhibiting the release of arachidonic acid from phospholipids. Inhibition of the release of arachidonic acid would result in the reduction of prostaglandin production since arachidonic acid, the precursor for prostaglandin biosynthesis, limits the production of prostaglandins (1, 2). Inhibition of arachidonic acid release from phospholipids was observed only with hydrocortisone; no significant effects were found with other steroids tested, including estradiol-17f3 and dehydroisoandrosterone (Fig. 4) .
We have previously demonstrated that exogenously supplied arachidonic acid stimulates the production of prostaglandins by MC5-5 cells (1, 2) . The levels of prostaglandins formed were found to be proportional to the concentration of arachidonic acid, at least up to 50 ,ug/ml. If hydrocortisone inhibits only the release of arachidonic acid from phospholipids and does not inhibit the prostaglandin synthetase, the ability of the cells to form prostaglandins from exogenous arachidonic acid should not be affected. As shown in Table 3 , the level of PGE2 increased from 2 ng/ml to 42 ng/ml and that of PGF2. increased from 0.3 ng/ml to 4.1 ng/ml in serum-free medium in the presence of 5 ,g of arachidonic acid. Indomethacin completely inhibited the formation of prostaglandins in the presence or absence of the added arachidonic acid, whereas hydrocortisone inhibited prostaglandin production in the absence of arachidonic acid, but not in its presence. Dehydroisoandrosterone, which previously was shown not to inhibit the production of prostaglandin or release of radioactive arachidonic acid, had no effect on the conversion of exogenous arachidonic acid into prostaglandins. Similar results were found when serum-supplemented medium was used as the incubation medium. In the absence of added arachidonic acid, hydrocortisone, after MEM(-) and MEM(+) are minimal essential medium containing 0 and 10% fetal bovine serum, respectively. MC5-5 cells (1.3 X 106 cells per dish) were preincubated with drugs for 2 hr and then incubated with test media containing the indicated amount of arachidonic acid and drugs (5 x 10-6 M) for 1 hr. Average values for prostaglandins from duplicate dishes are given. a Arachidonic acid stimulates prostaglandin production less in serum-supplemented medium than it does in serum-free medium. This is probably due to a tight binding of arachidonic acid to serum proteins. $ Expected values obtained similarly as described for * and t.
preincubation with the cells, inhibited between 70 and 80% of the prostaglandin production. In the presence of added arachidonic acid, prostaglandin levels were increased. Hydrocortisone did not inhibit the formation of prostaglandins from arachidonic acid. The inhibition of prostaglandin production by hydrocortisone in serum-supplemented medium containing arachidonic acid was as expected if the hydrocortisone inhibited only the production of prostaglandins by the cells from serum-supplemented medium alone. The possibility that hydrocortisone accelerated the catabolism of prostaglandins and thereby reduced prostaglandin levels was also investigated. Dishes of cells growing in serum-supplemented medium in the presence and absence of hydrocortisone were incubated with 2 Inhibition of prostaglandin production by indomethacin and hydrocortisone cannot be due to their effects on the release of preformed prostaglandins because intracellular prostaglandins in hydrocortisone-and indomethacin-treated cells were found to be lower than those in the control cells, 70% and 8%, respectively.
DISCUSSION
Inhibition of prostaglandin synthesis in MC5-5 cells by antiinflammatory corticosteroids at low concentrations is in agreement with the inhibition found in rheumatoid synovia (8) and mouse fibrosarcoma cells (7) . The results presented here demonstrate that the inhibition by hydrocortisone is due to block of the release of arachidonic acid from phospholipids and not due to inhibition of prostaglandin synthetase. Two lines of evidence support this conclusion: (i) Hydrocortisone reduces. the release of arachidonic acid from the phospholipids of the cells; and (ii) no inhibition of prostaglandin formation is observed when exogenously supplied arachidonic acid is used as substrate for the formation of prostaglandins by the cells. Hydrocortisone does not affect the catabolic rate of the prostaglandins.
Many cells and most organs in culture medium produce prostaglandins, yet very little is known about the mechanisms underlying prostaglandin production. Our studies demonstrate that the release of arachidonic acid from the phospholipids of the cells (in addition to the presence of this compound originally in serum), presumably by activation of phospholipases either directly or indirectly, may be an important factor in prostaglandin biosynthesis. Prostaglandins may play a role in the mediation of the inflammatory response (3). Our findings that corticosteroids inhibit the release of arachidonic acid from phospholipids with a resultant reduction of prostaglandin formation suggests strongly that this mechanism may be the basis for their anti-inflammatory effects. Gryglewski et al. (10) reached similar conclusions from their study with perfused guinea pig lungs. This mechanism of corticosteroid action may explain the failures of previous attempts to inhibit the formation of prostaglandins from arachidonic acid by microsomal enzyme preparations (4, 5) . One exception was the observation by Greaves and McDonald-Gibson (6), who found partial inhibition of prostaglandin formation by fluocinolone, but not hydrocortisone, with skin homogenates as the source of enzyme. The same investigators, however, reported later that no inhibition was observed when microsomal enzyme preparations were used (15) .
The anti-inflammatory action of corticosteroids is thought to be mediated in part by stabilization of plasma and lysosomal membranes (16) , although studies with phagocytic cells and bactericidal systems have failed to support this concept (17, 18) . The inhibition of arachidonic acid release by corticosteroids could result from stabilization of the cellular membranes, thereby rendering the phospholipids less accessible to phospholipases; however, the inhibition of release could also result directly from inhibition of phospholipase activity or indirectly from the corticosteroids' effect on cellular metabolism.
